1. MacDowella KS, Marsád MD, Buenachea E, Villatoro JML, Moreno B, et al. Inflammatory and antioxidant pathway dysfunction in borderline personality disorder. Psychiatry Res 2020;284:112782
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed). Arlington, VA: American Psychiatric Publishing; 2013.
3. Zimmerman M, Mattia JI. Axis I diagnostic comorbidity and borderline personality disorder. Compr Psychiatry 1999;40:245-252.
4. Anderson G. Pathoetiology and pathophysiology of borderline personality: role of prenatal factors, gut microbiome, mu- and kappa-opioid receptors in amygdala-PFC interactions. Prog Neuropsychopharmacol Biol Psychiatry 2020;98:109782
5. Lee RJ, Gozal D, Coccaro EF, Fanning J. Narcissistic and borderline personality disorders: relationship with oxidative stress. J Pers Disord 2020;34:6-24.
7. Saccora LF, Schilliger Z, Dayer A, Perroud N, Piguet C. Inflammation, anxiety, and stress in bipolar disorder and borderline personality disorder: a narrative review. Neurosci Biobehav Rev 2021;127:184-192.
9. Minutolo G, Petrali A, Dipasquale S, Aguglia E. Nitric oxide in patients with schizophrenia: the relationship with the severity of illness and the antipsychotic treatment. Expert Opin Pharmacother 2012;13:1989-1997.
12. Aydemir Ö, Çubukçuoğlu Z, Erdin S, Taş C, Onur E, Berk M. Oxidative stress markers, cognitive functions, and psychosocial functioning in bipolar disorder: an empirical cross-sectional study. Braz J Psychiatry 2014;36:293-297.
13. Sorias S, Saygılı R, Elbi H. [DSM-III-R structured clinical interview Turkish version SCID-II personality disorders form]. Bornova, Izmir: Ege University Press; 1990,Turkish.
14. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988;56:893-897.
15. Hisli N. [A Study on the Validity of the Beck Depression Inventory]. Turk Psikol Derg 1988;22:118-126. Turkish.
18. Rujescu D, Giegling I, Mandelli L, Schneider B, Hartmann AM, Schnabel A, et al. NOS-I and -III gene variants are differentially associated with facets of suicidal behavior and aggression-related traits. Am J Med Genet B Neuropsychiatr Genet 2008;147B:42-48.
20. Köse SS, Erbaş O. Personality disorders diagnosis, causes, and treatments. Demiroglu Sci Univ Florence Nightingale J Transplant 2020;5:22-31.
21. Reif A, Jacob CP, Rujescu D, Herterich S, Lang S, Gutknecht L, et al. Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans. Arch Gen Psychiatry 2009;66:41-50.
23. Eli R, Fasciano J. A chronopharmacological diagnostic test and treatment for bipolar disorder and depression: nitric oxide release during sleep causes it to become depressogenic in a subset of patients. Med Hypotheses 2006;66:72-75.
24. Kielstein H, Suntharalingam M, Perthel R, Song R, Schneider SM, Martens-Lobenhoffer J, et al. Role of the endogenous nitric oxide inhibitor asymmetric dimethylarginine (ADMA) and brain-derived neurotrophic factor (BDNF) in depression and behavioural changes: clinical and preclinical data in chronic kidney disease. Nephrol Dial Transplant 2015;30:1699-1705.
26. Manosso LM, Camargo A, Dafre AL, Rodrigues ALS. Vitamin E for the management of major depressive disorder: possible role of the anti-inflammatory and antioxidant systems. Nutr Neurosci 2020;25:1310-1324.
27. Wójcicka G, Jamroz-Wiśniewska A, Czechowska G, Korolczuk A, Marciniak S, Bełtowsk J. The paraoxonase 1 (PON1), platelet-activating factor acetylohydrolase (PAF-AH) and dimethylarginine dimethylaminohydrolase (DDAH) activity in the metformin treated normal and diabetic rats. Eur J Pharmacol 2016;789:187-194.
28. Hurşitoğlu O, Orhan FÖ, Kurutaş EB, Doğaner A, Durmuş HT, Kopar H. Diagnostic performance of increased malondialdehyde level and oxidative stress in patients with schizophrenia. Noro Psikiyatr Ars 2021;58:184-188.
29. Sydow K, Münzel T. ADMA and oxidative stress. Atheroscler Suppl 2003;4:41-51.
30. Coccaro EF, Lee R, Gozal D. Elevated plasma oxidative stress markers in individuals with intermittent explosive disorder and correlation with aggression in humans. Biol Psychiatry 2016;79:127-135.
32. Kamal NAM, Loo JL, Goon JA, Damanhuri HA, Sharip S, Saini SM, et al. Oxidative stress biomarkers in bipolar disorder with suicidal behavior: a systematic review. J Pharm Negat Results 2019;10:6-15.
33. Zincir SB, Zincir S. [Role of Asymmetric Dimethylarginine in Psychiatric Disorders]. Curr Approaches Psychiatry 2014;6:355-362. Turkish.